ReviewPharmaceuticals (Basel, Switzerland)2022

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.

Austin Lui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.